Previous 10 | Next 10 |
2023-12-29 15:14:25 ET Summary HRTX's Zynrelef sales are back on track, with potential for significant growth pending approval of a supplemental New Drug Application. Aponvie sales have been underwhelming thus far and probably won't contribute much to HRTX's revenues in the near t...
2023-11-30 09:00:00 ET Summary Heron Therapeutics develops solutions for pain and discomfort associated with chemotherapy and surgery, with four FDA-approved products. The company underwent a leadership change and implemented a plan to improve efficiency and profitability. Zyn...
2023-11-24 11:48:07 ET Penny stocks are highly speculative equities priced under $5 per share. They grab attention for their rapid rally potential even if the risks give most investors pause. Still, short-term traders look for volatile penny stock picks for explosive upside moves, espec...
2023-11-20 11:35:20 ET More on Heron Therapeutics Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M Seeking Alpha’s Quant Rating on Heron Therapeutics For further details see: Heron Therapeutics says chief development...
2023-11-17 11:19:16 ET When it comes to finding penny stocks to buy , there are plenty of things you’ll need to make note of. Sure, broader stock market news trends don’t directly influence cheap stocks. Even if the stock market is down like it is today, there are sure to ...
2023-11-15 12:35:40 ET A California-based %Biotech company is stealing the show so far during Wednesday’s session following yesterday’s earnings beat. According to some analysts, the company beat EPS by $0.14. Shares of %HeronTherapeutics (Nasdaq: HRTX) rallied str...
2023-11-15 12:32:14 ET DENVER, Colo., Nov. 15, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Cormedix Inc (NASDAQ: CRMD), SciSparc Ltd (NASDAQ: SPRC), Solid Biosciences Inc (NASDAQ: SLDB), Heron ...
2023-11-14 19:45:27 ET Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secretary Craig Collard - Chief Executive Officer Ry...
2023-11-14 16:08:05 ET More on Heron Therapeutics Heron Therapeutics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Heron Therapeutics Historical earnings data for Heron Therapeutics Financial information for Heron Therapeutics For fu...
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance PR Newswire Heron is increasing full-year 2023 Net Product Sales guidance for the oncology care franchise to a range of $104 million to $106 million from a prior range of...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN DIEGO , May 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechn...
2024-05-27 10:45:03 ET Heron Therapeutics Inc (HRTX) HRTX is trading UP for the last 5 days, and it at trading at $2.86 with volume of 6,916,602 and a one day change of $0.02 (0.53%). Heron Therapeutics Inc has a 52-week low of 0.50 and a 52-week high of $3.22. The business's 50-day...